BR102020005993A2 - AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES - Google Patents
AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES Download PDFInfo
- Publication number
- BR102020005993A2 BR102020005993A2 BR102020005993-9A BR102020005993A BR102020005993A2 BR 102020005993 A2 BR102020005993 A2 BR 102020005993A2 BR 102020005993 A BR102020005993 A BR 102020005993A BR 102020005993 A2 BR102020005993 A2 BR 102020005993A2
- Authority
- BR
- Brazil
- Prior art keywords
- açaí
- microcapsules
- pulp
- açaí pulp
- mart
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 38
- 230000008569 process Effects 0.000 title claims abstract description 17
- 244000207620 Euterpe oleracea Species 0.000 title abstract description 34
- 235000012601 Euterpe oleracea Nutrition 0.000 title abstract description 32
- 238000012545 processing Methods 0.000 title description 3
- 239000003094 microcapsule Substances 0.000 claims abstract description 45
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 27
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 20
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 20
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229930003935 flavonoid Natural products 0.000 claims abstract description 16
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 16
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 14
- 239000008393 encapsulating agent Substances 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 9
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 7
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 7
- 208000032928 Dyslipidaemia Diseases 0.000 claims abstract description 6
- 208000017170 Lipid metabolism disease Diseases 0.000 claims abstract description 6
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 6
- 235000015243 ice cream Nutrition 0.000 claims abstract description 6
- 241000195940 Bryophyta Species 0.000 claims abstract description 5
- 206010020772 Hypertension Diseases 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 235000011929 mousse Nutrition 0.000 claims abstract description 5
- 208000008589 Obesity Diseases 0.000 claims abstract description 4
- 235000020824 obesity Nutrition 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 33
- 241000202707 Euterpe Species 0.000 claims description 16
- 230000000975 bioactive effect Effects 0.000 claims description 14
- 108010046377 Whey Proteins Proteins 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 13
- 235000021119 whey protein Nutrition 0.000 claims description 13
- 241000254113 Tribolium castaneum Species 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 244000017020 Ipomoea batatas Species 0.000 claims description 8
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 108010076119 Caseins Proteins 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 150000002989 phenols Chemical class 0.000 claims description 6
- -1 caseinates Proteins 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000012512 characterization method Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 235000013365 dairy product Nutrition 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 230000000871 hypocholesterolemic effect Effects 0.000 claims description 2
- 229920001592 potato starch Polymers 0.000 claims description 2
- 238000004166 bioassay Methods 0.000 claims 3
- 238000010256 biochemical assay Methods 0.000 claims 3
- 238000004945 emulsification Methods 0.000 claims 3
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims 1
- 230000002484 anti-cholesterolemic effect Effects 0.000 claims 1
- 238000002792 antioxidant assay Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 45
- 235000013305 food Nutrition 0.000 abstract description 24
- 239000007787 solid Substances 0.000 abstract description 12
- 239000002417 nutraceutical Substances 0.000 abstract description 7
- 235000021436 nutraceutical agent Nutrition 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 6
- 230000006806 disease prevention Effects 0.000 abstract description 4
- 244000288157 Passiflora edulis Species 0.000 abstract description 3
- 235000000370 Passiflora edulis Nutrition 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 230000036642 wellbeing Effects 0.000 abstract description 3
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract description 2
- 208000001280 Prediabetic State Diseases 0.000 abstract description 2
- 239000012752 auxiliary agent Substances 0.000 abstract description 2
- 235000012970 cakes Nutrition 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 abstract description 2
- 235000014510 cooky Nutrition 0.000 abstract description 2
- 201000009104 prediabetes syndrome Diseases 0.000 abstract description 2
- 235000020965 cold beverage Nutrition 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 235000013399 edible fruits Nutrition 0.000 description 18
- 239000000843 powder Substances 0.000 description 17
- 238000009472 formulation Methods 0.000 description 16
- 235000010208 anthocyanin Nutrition 0.000 description 15
- 229930002877 anthocyanin Natural products 0.000 description 15
- 239000004410 anthocyanin Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 150000004636 anthocyanins Chemical class 0.000 description 14
- 235000016709 nutrition Nutrition 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000012000 cholesterol Nutrition 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 9
- 235000003650 acai Nutrition 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 8
- 229910002012 Aerosil® Inorganic materials 0.000 description 7
- 239000005913 Maltodextrin Substances 0.000 description 7
- 229920002774 Maltodextrin Polymers 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 7
- 229940035034 maltodextrin Drugs 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 244000215068 Acacia senegal Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 235000016213 coffee Nutrition 0.000 description 5
- 235000013353 coffee beverage Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 5
- 244000185722 Euterpe edulis Species 0.000 description 4
- 235000006581 Euterpe edulis Nutrition 0.000 description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 description 4
- 102000015779 HDL Lipoproteins Human genes 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 4
- 238000012742 biochemical analysis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 244000226021 Anacardium occidentale Species 0.000 description 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 3
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 3
- 241000254086 Tribolium <beetle> Species 0.000 description 3
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000020226 cashew nut Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 3
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- COAWNPJQKJEHPG-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1lambda^{4}-chromen-1-ylium chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 COAWNPJQKJEHPG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000254171 Curculionidae Species 0.000 description 2
- USNPULRDBDVJAO-YRBSALHSSA-O Cyanidin 3-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](Oc2c(-c3cc(O)c(O)cc3)[o+]c3c(c(O)cc(O)c3)c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 USNPULRDBDVJAO-YRBSALHSSA-O 0.000 description 2
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 2
- 241001677214 Euterpe precatoria Species 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 2
- 241001479489 Peponocephala electra Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000003293 cardioprotective effect Effects 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- USNPULRDBDVJAO-FXCAAIILSA-O cyanidin 3-O-rutinoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(=[O+]C3=CC(O)=CC(O)=C3C=2)C=2C=C(O)C(O)=CC=2)O1 USNPULRDBDVJAO-FXCAAIILSA-O 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 2
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 229960001331 keracyanin Drugs 0.000 description 2
- 230000004132 lipogenesis Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 2
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 2
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 2
- PADQINQHPQKXNL-LSDHHAIUSA-N (+)-dihydrokaempferol Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C=C1 PADQINQHPQKXNL-LSDHHAIUSA-N 0.000 description 1
- QKPLRMLTKYXDST-NSEZLWDYSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;hydrochloride Chemical compound Cl.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O QKPLRMLTKYXDST-NSEZLWDYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- SCZVLDHREVKTSH-UHFFFAOYSA-N 4',5,7-trihydroxy-3'-methoxyflavone Chemical compound C1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 SCZVLDHREVKTSH-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000004749 Annona muricata Species 0.000 description 1
- 235000007747 Annona muricata Nutrition 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241001133958 Calyptronoma plumeriana Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 101100010343 Drosophila melanogaster lobo gene Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000007951 Hancornia speciosa Species 0.000 description 1
- 235000001469 Hancornia speciosa Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- ONQVTPMFYSRRLL-LGWXHOMDSA-O Peonidin 3-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](Oc2c(-c3cc(OC)c(O)cc3)[o+]c3c(c(O)cc(O)c3)c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 ONQVTPMFYSRRLL-LGWXHOMDSA-O 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- YXHFXGHAELQJGK-PGPONNFDSA-N Scoparin Chemical compound C1=C(O)C(OC)=CC(C=2OC3=C([C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C(O)=CC(O)=C3C(=O)C=2)=C1 YXHFXGHAELQJGK-PGPONNFDSA-N 0.000 description 1
- RTRPDMVGOFRVOY-UHFFFAOYSA-N Scoparin Natural products COc1cc(ccc1O)C2=CC(=O)c3c(O)cc(O)c(OC4OC(CO)C(O)C(O)C4O)c3O2 RTRPDMVGOFRVOY-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000003214 anti-biofilm Effects 0.000 description 1
- 230000001708 anti-dyslipidemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- UOSZQIQUCYTISS-UHFFFAOYSA-N chrysoeriol Natural products C1=C(O)C(C)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 UOSZQIQUCYTISS-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- ZPPQIOUITZSYAO-AOBOYTTNSA-O cyanidin 3-O-beta-D-sambubioside Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O)CO)C1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 ZPPQIOUITZSYAO-AOBOYTTNSA-O 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000019543 dairy drink Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000015114 espresso Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 230000008798 inflammatory stress Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000001000 lipidemic effect Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000010198 maturation time Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- DCYOADKBABEMIQ-OWMUPTOHSA-N myricitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=C(O)C=2)OC2=CC(O)=CC(O)=C2C1=O DCYOADKBABEMIQ-OWMUPTOHSA-N 0.000 description 1
- DCYOADKBABEMIQ-FLCVNNLFSA-N myricitrin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2cc(O)c(O)c(O)c2)Oc2c(c(O)cc(O)c2)C1=O DCYOADKBABEMIQ-FLCVNNLFSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 238000013379 physicochemical characterization Methods 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 1
- VVXVTYYCCQZUKK-UHFFFAOYSA-N quercetin 3-rutinoside Natural products CC1OC(OCC2OC(OC3=C(Oc4ccc(O)c(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O VVXVTYYCCQZUKK-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000013878 renal filtration Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- ROCUOVBWAWAQFD-UHFFFAOYSA-N velutin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(OC)=C1 ROCUOVBWAWAQFD-UHFFFAOYSA-N 0.000 description 1
- WHDYZMQZOAULDI-UHFFFAOYSA-N velutin Natural products Cc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(C)c3 WHDYZMQZOAULDI-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
microcápsulas da polpa de açaí (euterpe oleracea mart.), processo de obtenção microcápsulas de açaí (euterpe oleracea mart.) e usos. são propostos microcápsulas de polpa de açaí, processo de obtenção de microcápsulas de maracujá e usos. a produção de microcápsulas da polpa de açaí utiliza a polpa de açaí padronizada, contendo princípios ativos (antocianidinas e flavonoides) nas microcápsulas de açaí que são revestidas com encapsulantes biocompatíveis e biodegradáveis, seguido pela secagem usando técnica de spray-dryer, apresentando-se em forma de micropartículas aqui também chamados de microcápsulas da polpa de açaí. as microcápsulas de polpa de açaí apresentam potencial aplicação como agentes auxiliares para prevenção de doenças e para manter o bem-estar, além de suas propriedades benéficas para saúde. as composições de microcápsulas de polpa de açaí no estado sólido têm propriedades benéficas para a saúde, devido a sua atividade antioxidante e na prevenção de pré-diabetes, diabetes, devido as suas propriedades hipoglicemiantes, bem como combate a obesidade, dislipidemia e hipertensão. adicionalmente, as microcápsulas da polpa de açaí podem ser utilizadas para a preparação de produtos alimentícios como sorvetes, mousses, bebidas geladas, bolos, cookies, suplementos alimentícios esportivos ou ainda cápsulas nutracêuticas.microcapsules from açaí pulp (euterpe oleracea mart.), process of obtaining açaí microcapsules (euterpe oleracea mart.) and uses. Açaí pulp microcapsules, the process for obtaining passion fruit microcapsules and uses are proposed. the production of açaí pulp microcapsules uses standardized açaí pulp, containing active ingredients (anthocyanidins and flavonoids) in açaí microcapsules that are coated with biocompatible and biodegradable encapsulants, followed by drying using a spray-dryer technique, presenting in form of microparticles here also called microcapsules of açaí pulp. Açaí pulp microcapsules have potential application as auxiliary agents for disease prevention and to maintain well-being, in addition to their beneficial health properties. Compositions of açaí pulp microcapsules in solid form have beneficial properties for health, due to their antioxidant activity and in the prevention of pre-diabetes, diabetes, due to their hypoglycemic properties, as well as combating obesity, dyslipidemia and hypertension. Additionally, açaí pulp microcapsules can be used to prepare food products such as ice creams, mousses, cold drinks, cakes, cookies, sports food supplements or even nutraceutical capsules.
Description
[001] A invenção se propõe a desenvolver uma composição de MICROCÁPSULAS DE POLPA DE AÇAÍ (Euterpe oleracea Mart) com funções nutricionais, funcionais e nutracêutica, devido às diversas propriedades medicinais do açaí, como ação antioxidante, anti-inflamatória, hipoglicemiante, cardioprotetora, anti-hipertensiva, prevenção de câncer, dentre outras. Contudo, a polpa de açaí apresenta alguns aspectos negativos, como fácil degradação pela incidência de luz, termo-degradação, fácil fermentação quando estocada a temperatura ambiente e que podem dificultar sua aplicação no desenvolvimento de composições, em alimentos nutracêuticos e bebidas geladas, sorvetes e mousse. Dessa forma, torna-se imprescindível sua modificação, como por exemplo sua microencapsulação com agentes encapsulantes adequados, a fim de mascarar e estabilizar os compostos fenólicos e seus constituintes lipídicos. Além disso, pretende-se obter composições com liberação imediata no trato gastrintestinal e estáveis físico-quimicamente. Os microencapsulados de polpa de açaí utilizam adjuvantes alimentícios protéicos, apresenta potencial aplicação como agentes auxiliares para prevenção de doenças e para manter o bem-estar, além de suas propriedades benéficas para saúde. Por fim, objetiva-se desenvolver composições de polpa de açaí no estado sólido com propriedades benéficas para a saúde, com características sensoriais atrativas, com aplicabilidade prática em alimentos nutracêuticos, e que também podem ser adicionados à sorvetes, bebidas geladas, mousses, além de produzir cápsulas farmacêuticas contendo os princípios ativos do açaí ou ainda como suplementos alimentícios para atletas de alta performance devido a suas propriedades antioxidantes e na prevenção de diabetes e pré-diabetes devido as suas propriedades hipoglicemiantes.[001] The invention proposes to develop a composition of AÇAÍ PULP MICROCAPSULAS (Euterpe oleracea Mart) with nutritional, functional and nutraceutical functions, due to the various medicinal properties of açaí, such as antioxidant, anti-inflammatory, hypoglycemic, cardioprotective action, antihypertensive, cancer prevention, among others. However, açaí pulp has some negative aspects, such as easy degradation due to the incidence of light, thermo-degradation, easy fermentation when stored at room temperature and that can hinder its application in the development of compositions, in nutraceutical foods and frozen drinks, ice cream and Mousse. Therefore, its modification is essential, such as its microencapsulation with suitable encapsulating agents, in order to mask and stabilize the phenolic compounds and their lipid constituents. In addition, it is intended to obtain compositions with immediate release in the gastrointestinal tract and physicochemically stable. Açaí pulp microencapsulates use protein food adjuvants, have potential application as auxiliary agents for disease prevention and to maintain well-being, in addition to their beneficial properties for health. Finally, the objective is to develop solid state açaí pulp compositions with beneficial properties for health, with attractive sensory characteristics, with practical applicability in nutraceutical foods, and which can also be added to ice cream, frozen drinks, mousses, in addition to produce pharmaceutical capsules containing the active ingredients of açaí or as food supplements for high-performance athletes due to its antioxidant properties and in the prevention of diabetes and pre-diabetes due to its hypoglycemic properties.
[002] O açaizeiro é uma palmeira típica encontrada nas planícies de inundação ao longo do estuário do rio Amazonas que apresenta cachos com drupe globosa com diâmetro variando de 1 a 2 cm, com epicóptero de uma semente amarelada e marrom, camada dura e muito fina que pode ser verde, conhecido como açaí branco, ou púrpura conhecido como açaí escuro de acordo com a variedade, e um mesocarpo com 1 a 2 mm de espessura (NERI-NUMA, I.A et al. Small Brazilian wild fruits: Nutrients, bioactive compounds, healthpromotion properties and commercial interest. Food research international, v. 103, p. 345-360, 2018).[002] The açaizeiro is a typical palm found in the floodplains along the estuary of the Amazon River that presents bunches with globose drupe with a diameter ranging from 1 to 2 cm, with epicopter of a yellowish and brown seed, hard and very thin layer which can be green, known as white açaí, or purple known as dark açaí, depending on the variety, and a mesocarp 1 to 2 mm thick (NERI-NUMA, IA et al. Small Brazilian wild fruits: Nutrients, bioactive compounds , healthpromotion properties and commercial interest. Food research international, v. 103, p. 345-360, 2018).
[003] Embora na terminologia vulgar seja mais conhecida como açaí, outras denominações são de uso freqüente nas áreas de ocorrência na Amazônia brasileira, porém de forma mais restrita, destacando-se os seguintes nomes: açaí do Pará, açaí do baixo amazonas, açaí de touceira, açaí de planta, juçara e juçara de touceira. Os dois últimos nomes são bastante usados no Estado do Maranhão. Convém ressaltar, ainda, que as outras espécies, do mesmo táxon genérico, ocorrentes na Amazônia, são igualmente denominadas de açaí, daí E. oleracea ser também chamada, em alguns locais, de açaí verdadeiro (DE OLIVEIRA, M.S.; DE CARVALHO, J.E.U. ; DO NASCIMENTO, W.M.O. Açaí (Euterpe oleracea Mart.). Funep, 2000).[003] Although in common terminology it is better known as açaí, other names are frequently used in areas of occurrence in the Brazilian Amazon, but in a more restricted way, with the following names standing out: açaí do Pará, açaí from the lower amazons, açaí of tussock, plant açaí, juçara and tussock juçara. The last two names are widely used in the State of Maranhão. It should also be noted that the other species, of the same generic taxon, occurring in the Amazon, are also called açaí, hence E. oleracea is also called, in some places, true açaí (DE OLIVEIRA, MS; DE CARVALHO, JEU ; DO NASCIMENTO, WMO Açaí (Euterpe oleracea Mart.). Funep, 2000).
[004] Segundo a Legislação do Ministério da Agricultura (BRASIL, Ministério da Agricultura. Coordenação de Inspeção Vegetal. Decreto nº 2.314, de 4 de setembro de 1997, art. 87, inciso II. Regulamentos Técnicos para Fixação dos Padrões de Identidade e Qualidade para polpa das seguintes frutas: acerola, cacau, cupuaçu, graviola, açaí, maracujá, caju, manga, goiaba, pitanga, uva, mamão, cajá, melão, mangaba, e para suco das seguintes frutas: maracujá, caju, caju alto teor de polpa, caju clarificado ou cajuína, abacaxi, uva, pêra, maçã, limão, lima ácida e laranja. Diário Oficial, Brasília, DF. Nº 01, DE 7 DE JANEIRO DE 2000) o fruto do açaí é classificado de acordo com a quantidade de sólidos totais em: grosso (Tipo A), que possui 14% de sólidos totais e aparência muito densa; em médio (Tipo B), que possui de 11% a 14% de sólidos totais e aparência densa; e fino (Tipo C), que contém de 8 a 11% de sólidos totais e aparência pouco densa.[004] According to the Legislation of the Ministry of Agriculture (BRASIL, Ministry of Agriculture. Coordination of Plant Inspection. Decree No. 2,314, of September 4, 1997, art. 87, item II. Technical Regulations for Establishing Identity and Quality Standards for pulp of the following fruits: acerola, cocoa, cupuaçu, soursop, açaí, passion fruit, cashew, mango, guava, cherry, grape, papaya, caja, melon, mangaba, and for juice of the following fruits: passion fruit, cashew, high content cashew açaí fruit is classified according to amount of total solids in: coarse (Type A), which has 14% total solids and very dense appearance; in medium (Type B), which has 11% to 14% total solids and dense appearance; and fine (Type C), which contains 8 to 11% total solids and has a thin appearance.
[005] Com o crescimento do mercado, esse produto passou a ser consumido também nas grandes capitais brasileiras, atingindo até alguns países como Japão, China e Estados Unidos (MENEZES, E.M.S; TORRES, A.T; SRUR, A.U.S. Valor nutricional da polpa de açaí (Euterpe oleracea Mart) liofilizada. Acta Amaz, v. 38, n. 2, p. 311-316, 2008). Todas as partes do açaí podem ser utilizadas, tanto a caroço que corresponde a 85% do peso total quanto a polpa que representa 15%, e o fruto não é só utilizado nas indústrias alimentícia e farmacêutica, mas também nas indústrias de cosméticos e automobilística.[005] With the growth of the market, this product started to be consumed also in large Brazilian capitals, reaching even some countries such as Japan, China and the United States (MENEZES, EMS; TORRES, AT; SRUR, AUS Nutritional value of açaí pulp (Euterpe oleracea Mart) freeze-dried. Acta Amaz, v. 38, n. 2, p. 311-316, 2008). All parts of the açaí can be used, both the stone, which corresponds to 85% of the total weight, and the pulp, which represents 15%, and the fruit is not only used in the food and pharmaceutical industries, but also in the cosmetics and automobile industries.
[006] O açaí vem sendo considerado uma superfruta devido a sua composição nutricional, chegando a ser considerado um alimento funcional, rico em proteínas, fibras, lipídios, vitamina E, e minerais como magnésio, ferro, cobre, boro e cromo, já a quantidade de carboidratos como glicose, frutose e sacarose é relativamente baixa entre 2,96% e 3,55% do total de recomendação do dia (MATIAS DOS SANTOS, G. et al. Correlação entre atividade antioxidante e compostos bioativos de polpas comerciais de açaí (Euterpe oleácea Mart). Archivos latinoamericanos de nutricion, v. 58, n. 2, p. 187-192, 2008; DE LIMA YAMAGUCHI, K. K. et al. Amazon acai: Chemistry and biological activities: A review. Food chemistry, v. 179, p. 137-151, 2015).[006] Açaí has been considered a superfruit due to its nutritional composition, coming to be considered a functional food, rich in proteins, fibers, lipids, vitamin E, and minerals such as magnesium, iron, copper, boron and chromium. amount of carbohydrates such as glucose, fructose and sucrose is relatively low between 2.96% and 3.55% of the total recommendation for the day (MATIAS DOS SANTOS, G. et al. Correlation between antioxidant activity and bioactive compounds from commercial açaí pulps (Euterpe oleácea Mart) Archivos latinoamericanos de nutricion, v. 58, n. 2, p. 187-192, 2008; DE LIMA YAMAGUCHI, KK et al. Amazon acai: Chemistry and biological activities: A review. 179, p. 137-151, 2015).
[007] Dias-Souza et al., 2018 (DIAS-SOUZA, M. V. et al. Euterpe oleracea pulp extract: Chemical analyses, antibiofilm activity against Staphylococcus aureus, cytotoxicity and interference on the activity of antimicrobial drugs. Microbial pathogenesis, v. 114, p. 29- 35, 2018) em seu estudo encontraram que o teor de carboidratos e proteínas das amostras estavam dentro dos valores estabelecidos pela legislação brasileira, 0,21 ± 0.13 g/g para carboidratos e 1,4 ± 0.75 g/g para proteínas.[007] Dias-Souza et al., 2018 (DIAS-SOUZA, MV et al. Euterpe oleracea pulp extract: Chemical analyses, antibiofilm activity against Staphylococcus aureus, cytotoxicity and interference on the activity of antimicrobial drugs. Microbial pathogenesis, v. 114 , p. 29-35, 2018) in their study found that the carbohydrate and protein content of the samples were within the values established by Brazilian legislation, 0.21 ± 0.13 g/g for carbohydrates and 1.4 ± 0.75 g/g for proteins.
[008] O alto teor de lipídios do açaí confere ao produto um elevado valor energético, representam 70-90% do total de calorias encontradas no suco, representados pelo ácido oléico e ácido palmítico. O alto teor de lipídios dá o suco de açaí um valor energético duas vezes superior às encontradas no leite (50 kcal/100 mL) (MENEZES, E.M.S; TORRES, A.T; SRUR, A.U.S. Valor nutricional da polpa de açaí (Euterpe oleracea Mart) liofilizada. Acta Amaz, v. 38, n. 2, p. 311-316, 2008; DE SOUZA, M.O. et al. Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition, v. 26, n. 7, p. 804-810, 2010). Assim, o consumo deste fruto proporciona uma boa ingestão de mono- e poliinsaturados.[008] The high lipid content of açaí gives the product a high energy value, representing 70-90% of the total calories found in the juice, represented by oleic acid and palmitic acid. The high content of lipids gives açaí juice an energy value twice as high as those found in milk (50 kcal/100 mL) (MENEZES, EMS; TORRES, AT; SRUR, AUS Nutritional value of açaí pulp (Euterpe oleracea Mart) Acta Amaz, v. 38, no. 2, p. 311-316, 2008; DE SOUZA, MO et al. Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition, v. 26, n. 7, p. 804-810, 2010). Thus, consumption of this fruit provides a good intake of mono- and polyunsaturated foods.
[009] No quadro 1 pode-se observar a composição centesimal do fruto achado por diversos autores.[009] Table 1 shows the proximate composition of the fruit found by several authors.
[010] Os diferentes valores nos resultados publicados são, provavelmente, devido ao processamento industrial, mas outro motivo pode ser a alta variabilidade genética das espécies, o solo em que foi plantado, a sazonalidade, tempo de colheita, época de maturação entre outros.
Quadro 1 - Composição centesimal do açaí (Euterpe oleracea) por diferentes autores em 100g do fruto.NEIDA, S.; ELBA, S. Caracterización del acai o manaca (Euterpe oleracea Mart.): un fruto del Amazonas. Archivoslatinoamericanos de nutrición, v. 57, n. 1, p. 94, 2007; MENEZES, E.M.S; TORRES, A.T; SRUR, A.U.S. Valor nutricional da polpa de açaí (Euterpe oleracea Mart) liofilizada. Acta Amaz, v. 38, n. 2, p. 311-316, 2008; FERNANDES, E.T.M. B. et al. Physicochemical composition, color and sensory acceptance of low-fat cupuaçu and açaí nectar: characterization and changes during storage. Food Science and Technology(Campinas), v. 36, n. 3, p. 413-420, 2016).[010] The different values in the published results are probably due to industrial processing, but another reason could be the high genetic variability of the species, the soil in which it was planted, seasonality, harvest time, maturation time, among others.
Table 1 - Proximate composition of açaí (Euterpe oleracea) by different authors in 100g of the fruit. NEIDA, S.; ELBA, S. Characterization of acai or manaca (Euterpe oleracea Mart.): a fruit from the Amazon. Archivoslatinoamericanos de Nutrición, v. 57, no. 1, p. 94, 2007; MENEZES, EMS; TOWERS, AT; SRUR, AUS Nutritional value of freeze-dried açaí (Euterpe oleracea Mart) pulp. Acta Amaz, v. 38, no. 2, p. 311-316, 2008; FERNANDES, ETMB et al. Physicochemical composition, color and sensory acceptance of low-fat cupuaçu and açaí nectar: characterization and changes during storage. Food Science and Technology(Campinas), v. 36, no. 3, p. 413-420, 2016).
[011] A polpa do fruto por apresentar funções nutritivas e terapêuticas, tornou-se cada vez mais objeto de estudo, atribuído principalmente à sua ação antioxidante, que parece contribuir para a prevenção de doenças. Entre os antioxidantes que se destacam e estão presentes na polpa do fruto, são, as antocianinas, os flavonóides e os compostos fenólicos (MATIAS DOS SANTOS, G. et al. Correlação entre atividade antioxidante e compostos bioativos de polpas comerciais de açaí (Euterpe oleácea Mart). Archivoslatinoamericanos de nutricion, v. 58, n. 2, p. 187- 192, 2008; VELASQUE, L. F. L.; LOBO, A. C. M. Revisão de literatura sobre os efeitos terapêuticos do açaí e sua importância na alimentação. Biosaúde, v. 18, n. 2, p. 97- 106, 2017).[011] The pulp of the fruit for presenting nutritional and therapeutic functions, has become increasingly object of study, mainly attributed to its antioxidant action, which seems to contribute to the prevention of disease. Among the antioxidants that stand out and are present in the fruit pulp are anthocyanins, flavonoids and phenolic compounds (MATIAS DOS SANTOS, G. et al. Correlation between antioxidant activity and bioactive compounds from commercial açaí pulps (Euterpe oleácea) Archivoslatinoamericanos de nutricion, v. 58, n. 2, p. 187- 192, 2008; VELASQUE, LFL; LOBO, ACM Literature review on the therapeutic effects of açaí and its importance in nutrition. Biohealth, v. 18 , no. 2, p. 97-106, 2017).
[012] A E. oleracea é caracterizada quimicamente pela presença de substâncias bioativas. Cerca de 90 substâncias têm sido descritos, dos quais aproximadamente 31% são composto por flavonoides, seguido de compostos fenólicos (23%), e antocianinas (9%) (DE LIMA YAMAGUCHI, K. K. et al. Amazon acai: Chemistry and biological activities: A review. Food chemistry, v. 179, p. 137-151, 2015).[012] E. oleracea is chemically characterized by the presence of bioactive substances. About 90 substances have been described, of which approximately 31% are composed of flavonoids, followed by phenolic compounds (23%), and anthocyanins (9%) (DE LIMA YAMAGUCHI, KK et al. Amazon acai: Chemistry and biological activities: A review. Food chemistry, v. 179, p. 137-151, 2015).
[013] Mulabagual e Calderon (MULABAGAL, V.; CALDERÓN, A.I. Liquid chromatography/mass spectrometry based fingerprinting analysis and mass profiling of Euterpe oleracea (açaí) dietary supplement raw materials. Foodchemistry, v. 134, n. 2, p. 1156-1164, 2012), utilizando técnica de cromatografia líquida aclopada a espectrometria de massas desenvolveram um método de análise de fingerprinting, identificaram vários flavonoides, ácidos fenólicos, antocianidinas e ácidos graxos, e dentre as substancias identificadas os flavonoides aparecem em maior quantidade. Os principais compostos identificados dentres eles: ácido vanílico, ácido protocatequeutico, scoparina, chrysoeriol, taxifolina, orientina, isorientina, vitexina, isovitexina, quercetina, quercetina-3 rutinosideo, quercetina- 3 glucosideo, kaempferol, kaempferolraminosideo, kaempferolrutenosideo, rutina, luteolina, apigenina, quercitrina e isoquercitrina.[013] Mulabagual and Calderon (MULABAGAL, V.; CALDERÓN, AI Liquid chromatography/mass spectrometry based fingerprinting analysis and mass profiling of Euterpe oleracea (açaí) dietary supplement raw materials. Foodchemistry, v. 134, n. 2, p. 1156 -1164, 2012), using coupled liquid chromatography technique and mass spectrometry, developed a fingerprinting analysis method, identified several flavonoids, phenolic acids, anthocyanidins and fatty acids, and among the substances identified, flavonoids appear in greater quantity. The main compounds identified were: vanillic acid, protocatecheutic acid, scoparin, chrysoeriol, taxifolin, orientin, isorientin, vitexin, isovitexin, quercetin, quercetin-3 rutinoside, quercetin-3 glucoside, kaempferol, kaempferolraminoside, kaempferoline, kaempferolrtin , quercitrin and isoquercitrin.
[014] Kang et al. (KANG, J. et al. Anti-oxidant capacities of flavonoid compounds isolated from acai pulp (Euterpe oleracea Mart.). FoodChemistry, v. 122, n. 3, p. 610-617,2010) em seu estudo observaram a presença de cinco flavonóides no fruto da Euterpe oleracea entre eles estão (2S,3S)-dihirokaempferol 3-O-b-D-glucosideo, (2R,3R)- dihidrokaempferol 3-O-b-D-glucosideo, isovitexina, velutina e 5,40 -Dihidroxi-7,30 ,50 –trimethoxiflavone.[014] Kang et al. (KANG, J. et al. Anti-oxidant capacities of flavonoid compounds isolated from acai pulp (Euterpe oleracea Mart.). FoodChemistry, v. 122, n. 3, p. 610-617,2010) in their study observed the presence of five flavonoids in the fruit of Euterpe oleracea among them are (2S,3S)-dihirokaempferol 3-ObD-glucoside, (2R,3R)-dihydrokaempferol 3-ObD-glucoside, isovitexin, velutin and 5,40-Dihydroxy-7.30 .50 -trimethoxyflavone.
[015] Em análise cromatográfica da polpa de açaí identificou a presença de uma quantidade significativa de 2 antocianinas, cianidina-3 glucosídeo e cianidia- 3 rutinosídeo considerando-as as mais predominantes no fruto (PACHECO-PALENCIA, L.A., DUNCAN, C.E., TALCOTT, S.T. Phytochemical composition and termal stability of two commercial açai species, Euterpe oleracea and Euterpe precatoria. Food chemistry, v. 115, n. 4, p. 1199-1205, 2009; DE LIMA YAMAGUCHI, K.K. et al. Amazon acai: Chemistry and biological activities: A review. Food chemistry, v. 179, p. 137-151, 2015; DE MOURA, R.S.; RESENDE, Â.C. Cardiovascular and metabolic effects of açaí, an Amazon plant. Journal of cardiovascular pharmacology, v. 68, n. 1, p. 19-26, 2016).[015] In chromatographic analysis of the açaí pulp identified the presence of a significant amount of 2 anthocyanins, cyanidin-3 glucoside and cyanidin-3 rutinoside considering them the most predominant in the fruit (PACHECO-PALENCIA, LA, DUNCAN, CE, TALCOTT , ST Phytochemical composition and thermal stability of two commercial açai species, Euterpe oleracea and Euterpe precatoria. Food chemistry, v. 115, n. 4, p. 1199-1205, 2009; DE LIMA YAMAGUCHI, KK et al. Amazon acai: Chemistry and biological activities: A review. Food chemistry, v. 179, p. 137-151, 2015; DE MOURA, RS; RESENDE, Â.C. Cardiovascular and metabolic effects of açaí, an Amazon plant. Journal of cardiovascular pharmacology, v. 68, no. 1, p. 19-26, 2016).
[016] Em outro estudo, foi possível identificar seis antocianinas em celulose liofilizada do fruto, entre as quais encontram-se: cianidina 3-glucosídeos; cianidina 3- rutinosídeo; cianidina-3-sambubiosídeo; peonidina-3- rutinosídeo; pelargonidina-3- glucosídeos, e delfinidina-3- glucosídeos (CARDOSO, L.M, et al. Chemical composition, characterization of anthocyanins and antioxidant potential of Euterpe edulis fruits: applicability on genetic, dyslipidemia and hepatic steatosis in mice. Nutrición hospitalaria: Organo oficial de la Sociedad española de nutrición parenteral y enteral, v. 32, n. 2, p. 702-709, 2015).[016] In another study, it was possible to identify six anthocyanins in freeze-dried cellulose of the fruit, among which are: cyanidin 3-glucosides; cyanidin 3-rutinoside; cyanidin-3-sambubioside; peonidin-3-rutinoside; pelargonidin-3-glucosides, and delphinidin-3-glucosides (CARDOSO, LM, et al. Chemical composition, characterization of anthocyanins and antioxidant potential of Euterpe edulis fruits: applicability on genetic, dyslipidemia and hepatic steatosis in mice. Hospital nutrition: Official organization de la Sociedad española de nutrición parenteral and enteral, v. 32, n. 2, p. 702-709, 2015).
[017] As antocianinas presentes no açaí podem oferecer uma nova fonte desses pigmentos e, desta forma, um estudo de formas de sua obtenção torna-se importante, visando ao aumento do rendimento, à redução do uso de produtos químicos e à maior estabilidade.[017] The anthocyanins present in açaí can offer a new source of these pigments and, thus, a study of ways to obtain it becomes important, aiming at increasing yield, reducing the use of chemical products and greater stability.
[018] As propriedades biológicas do açaí são relacionadas a atividade anti-proliferativa, antiinflamatória, antioxidante e efeito cardioprotetor, vários estudos demonstram suas ações.[018] The biological properties of açaí are related to anti-proliferative, anti-inflammatory, antioxidant and cardioprotective activity, several studies demonstrate their actions.
[019] Cordeiro et al.(2017), (CORDEIRO, V.S.C et al. Euterpe oleracea Mart. seed extract protects against renal injury in diabetic and spontaneously hypertensive rats: role of inflammation and oxidative stress. European jornal of nutrition, v. 57, n. 2, p. 817-832, 2017)observaram que os resultados do seu estudo indicaram que o extrato da polpa do açaí reduziu substancialmente a lesão renal, prevenindo contra a disfunção renal pela redução da inflamação, estresse oxidativo e melhorar a barreira de filtração renal, proporcionando um recurso nutricional para prevenção de diabéticos e hipertensos relacionadas a nefropatia.[019] Cordeiro et al.(2017), (CORDEIRO, VSC et al. Euterpe oleracea Mart. seed extract protects against renal injury in diabetic and spontaneously hypertensive rats: role of inflammation and oxidative stress. European journal of nutrition, v. 57 , no. 2, p. 817-832, 2017) observed that the results of their study indicated that the açaí pulp extract substantially reduced kidney damage, preventing kidney dysfunction by reducing inflammation, oxidative stress and improving the barrier of renal filtration, providing a nutritional resource for the prevention of diabetic and hypertensive patients related to nephropathy.
[020] Um estudo com ratos, relacionado a obesidade e esteatose hepática induzida por dieta rica em gordura com e sem suplementação de extrato de açaí, houve redução da lipogênese, aumento da excreção de colesterol e melhora do estresse oxidativo no fígado, quando comparado ao grupo que não foi suplementado (DE OLIVEIRA, P.R.B. et al. Euterpe oleracea Mart.-derived polyphenols protect mice from dietinduced obesity and fatty liver by regulating hepatic lipogenesis and cholesterol excretion. PloSone, v. 10, n. 12, p. e0143721, 2015).[020] A study with rats, related to obesity and hepatic steatosis induced by a high-fat diet with and without supplementation of açaí extract, there was a reduction in lipogenesis, increased cholesterol excretion and improved oxidative stress in the liver, when compared to group that was not supplemented (DE OLIVEIRA, PRB et al. Euterpe oleracea Mart.-derived polyphenols protect mice from diet induced obesity and fatty liver by regulating hepatic lipogenesis and cholesterol excretion. PloSone, v. 10, n. 12, p. e0143721, p. e0143721, p. 2015).
[021] O açaí é um dos alimentos que vem mostrando também esses efeitos benéficos, em modelos experimentais na prevenção e controle da doenças relacionas a síndrome metabólica, em um estudo com adultos com sobrepeso, observou que a suplementação de 200g polpa de açaí por dia, em indivíduos com sobrepeso e após um mês de administração da polpa de açaí, houve diminuição nos níveis médio de glicemia em jejum, de insulina sérica, colesterol total e LDLcolesterol (lipoproteína de baixa densidade) (UDANI, J.K. et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutrition journal, v. 10, n. 1, p. 45, 2011).[021] Açaí is one of the foods that has also shown these beneficial effects, in experimental models in the prevention and control of diseases related to metabolic syndrome, in a study with overweight adults, observed that the supplementation of 200g açaí pulp per day , in overweight individuals and after one month of administration of açaí pulp, there was a decrease in the mean levels of fasting glucose, serum insulin, total cholesterol and LDL-cholesterol (low-density lipoprotein) (UDANI, JK et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutrition journal, v. 10, n. 1, p. 45, 2011).
[022] O impacto das propriedades do açaí também foi observado em um estudo onde houve redução do colesterol total, LDL-colesterol e triglicerídeos no sangue, porém não houve alteração no colesterol HDL (lipoproteína de alta densidade) e VLDL (lipoproteína de muito baixa densidade) (YUYAMA, L. K. O. et al. Physicochemical characterization of acai juice of Euterpe precatoria Mart. from different amazonian ecosystems. ActaAmazonica, v. 41, n. 4, p. 545- 552, 2011).[022] The impact of the properties of açaí was also observed in a study where there was a reduction in total cholesterol, LDL-cholesterol and triglycerides in the blood, but there was no change in HDL (high density lipoprotein) and VLDL (very low lipoprotein) cholesterol density) (YUYAMA, LKO et al. Physicochemical characterization of acai juice of Euterpe precatoria Mart. from different amazonian ecosystems. ActaAmazonica, v. 41, n. 4, p. 545-552, 2011).
[023] Fernando (2013)(FERNANDO, F.S.L. Avaliação do efeito das bebidas de açaí no perfil lipídico e glicêmico em ratos wistar. São Carlos: Dissertação (mestrado), UFSCar, 2013), em uma pesquisa realizada com ratos que ingeriram a polpa do açaí diariamente por quarenta e cinco dias, detectou que o seu consumo diário promove reduções nos níveis séricos de glicose, porém não há diferença significativa nessa redução contrastando o estudo de Udani et al. (2011) (UDANI, J.K. et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutrition journal, v. 10, n. 1, p. 45, 2011).[023] Fernando (2013)(FERNANDO, FSL Evaluation of the effect of açaí drinks on the lipid and glycemic profile in wistar rats. São Carlos: Dissertation (Masters), UFSCar, 2013), in a research carried out with rats that ingested the pulp of açaí daily for forty-five days, detected that its daily consumption promotes reductions in serum glucose levels, but there is no significant difference in this reduction, contrasting the study by Udani et al. (2011) (UDANI, JK et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutrition journal, v. 10, n. 1, p. 45, 2011 ).
[024] Com a crescente incidência de doenças crônicas e suas complicações é importante investigar o potencial efeito benéfico do fruto do açaí, e vias metabólicas envolvidas. Embora, existam muitos relatos dos efeitos benéficos de antocianinas, estudos que testem doses fisiologicamente relevantes destes compostos ainda são escassos.[024] With the increasing incidence of chronic diseases and their complications it is important to investigate the potential beneficial effect of the acai berry, and metabolic pathways involved. Although there are many reports of beneficial effects of anthocyanins, studies testing physiologically relevant doses of these compounds are still scarce.
[025] Com o intuito de proteger a oxidação, degradação e secar suspensões sólidas a indústria de alimentos investiu na técnica de secagem por spray dryer, atualmente esse procedimento é aplicado principalmente em compostos bioativos e probióticos (GOUIN, S. Microencapsulation: industrial appraisal of existing Technologies and trends. Trends in food Science & technology, v. 15, n. 7-8, p. 330- 347, 2004).[025] In order to protect the oxidation, degradation and drying of solid suspensions, the food industry invested in the technique of spray dryer drying, currently this procedure is applied mainly to bioactive and probiotic compounds (GOUIN, S. Microencapsulation: industrial appraisal of existing Technologies and trends. Trends in food Science & technology, v. 15, n. 7-8, p. 330-347, 2004).
[026] O Spray dryer é uma alternativa de processo de secagem de alimentos que vem sendo amplamente utilizado na microencapsulação de ingredientes suscetíveis à deterioração por agentes externos, e consiste no encapsulamento de um agente ativo em uma matriz polimérica, para protegê-lo de condições adversas (TONON, R. V.; BRABET, C.; HUBINGER, M. D. Anthocyanin stability and antioxidante activity of spraydried açai (Euterpe oleracea Mart.) juice produced with diferente carrier agents. Food Research International, v. 43, n. 3, p. 907-914, 2010).[026] The Spray dryer is an alternative food drying process that has been widely used in the microencapsulation of ingredients susceptible to deterioration by external agents, and consists of the encapsulation of an active agent in a polymeric matrix, to protect it from conditions (TONON, RV; BRABET, C.; HUBINGER, MD Anthocyanin stability and antioxidant activity of spraydried açai (Euterpe oleracea Mart.) juice produced with different carrier agents. Food Research International, v. 43, n. 3, p. 907 -914, 2010).
[027] O suco de fruta em pó obtido por essa técnica pode apresentar algumas dificuldades, tais como viscosidade, higroscopicidade e baixa solubilidade. Além disso, a aderência de gotas nas paredes da câmara de secagem diminui o rendimento do processo (SANTANA, A. A. et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v. 212, p. 1-9, 2016).[027] The powdered fruit juice obtained by this technique can present some difficulties, such as viscosity, hygroscopicity and low solubility. In addition, the adherence of droplets to the walls of the drying chamber decreases the process yield (SANTANA, AA et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v 212, p. 1-9, 2016).
[028] Uma maneira de evitar esses problemas é adicionar agentes antes da secagem por spray, devido seu alto peso molecular, aumenta a temperatura de transição para vidro do produto (SANTANA, A. A. et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v. 212, p. 1-9, 2016).[028] One way to avoid these problems is to add agents before spray drying, because their high molecular weight increases the product's glass transition temperature (SANTANA, AA et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v. 212, p. 1-9, 2016).
[029] Os agentes carreadores mais comum utilizado nessa técnica de secagem de polpas de frutas são amidos e seus derivados, algumas gomas, lipídeos e proteínas, principalmente devido a sua alta solubilidade e baixa viscosidade, que são condições importantes para o processo de secagem por spray dryer (QUEK, S. Y.; CHOK, N. K. & SWEDLUND, P. The physicochemical properties of spray-dried water melon powders. Chemical Engineering and Processing: Process Intensification, v. 46, n. 5, p. 386-392, 2007).[029] The most common carrier agents used in this technique of drying fruit pulps are starches and their derivatives, some gums, lipids and proteins, mainly due to their high solubility and low viscosity, which are important conditions for the drying process by spray dryer (QUEK, SY; CHOK, NK & SWEDLUND, P. The physicochemical properties of spray-dried water melon powders. Chemical Engineering and Processing: Process Intensification, v. 46, n. 5, p. 386-392, 2007) .
[030] O uso de whey protein é um produto interessante para encapsulamento pois seu material de parede apresenta boa propriedade emulsificante desejada, e a maior fração dessas proteínas são capazes de construir géis térmicos insolúvel em água, e estabilizando as antocianinas em condições ácidas (pH ≥ 1,5) (BETZ, M.; KULOZIK, U. Microencapsulation of bioactive bilberry anthocyanins by means of whey protein gels. Procedia Food Science, v. 1, p. 2047-2056, 2011).[030] The use of whey protein is an interesting product for encapsulation because its wall material has good desired emulsifying property, and the largest fraction of these proteins are capable of building water-insoluble thermal gels, and stabilizing anthocyanins in acidic conditions (pH ≥ 1.5) (BETZ, M.; KULOZIK, U. Microencapsulation of bioactive bilberry anthocyanins by means of whey protein gels. Procedia Food Science, v. 1, p. 2047-2056, 2011).
[031] Em relação ao pó de açaí produzido por spray dryer, o alto teor de lipídeos na polpa de açaí leva a problemas durante este processo, causando incrustação do bico de pulverização. Em um estudo de Tonon, Brabete Hubinger (2008) (TONON, R.V.; BRABET, C.; HUBINGER, M.D. Influence of process conditions on the physicochemical properties of açai (Euterpe oleraceae Mart.) powder produced by spray drying.Journal of Food Engineering, v. 88, n. 3, p. 411-418, 2008), a polpa de açaí foi filtrada anteriormente, com o intuito de reduzir o teor de lipídeos e obteve resultados satisfatórios para a formação de pó.[031] Regarding the açaí powder produced by spray dryer, the high content of lipids in the açaí pulp leads to problems during this process, causing incrustation of the spray nozzle. In a study by Tonon, Brabete Hubinger (2008) (TONON, RV; BRABET, C.; HUBINGER, MD Influence of process conditions on the physicochemical properties of açai (Euterpe oleraceae Mart.) powder by spray drying. , v. 88, n. 3, p. 411-418, 2008), the açaí pulp was previously filtered, in order to reduce the lipid content and obtained satisfactory results for the formation of powder.
[032] Pesquisa e desenvolvimento de encapsulação de antocianidinas, astaxantina, outros betacarotenóides, extratos enriquecidos com antocianidinas com outras polpas de frutas e polpa de açaí foram obtidos utilizando diferentes técnicas, incluindo spray dryer. Pesquisa de SHEN & QUEK (2014) desenvolveu microencapsulados de produto comercial, Bioastina® enriquecida com 5% de astaxanthina, e agentes encapsulantes óleo de girassol, wheyprotein, caseína sódica e fibra de milho solúvel 70. Nesta composição os pesquisadores não utilizaram, gelatina nem aerosil na composição (SHEN, Q.; QUEK, S. Y. Microencapsulation of astaxanthin with blend soft milk protein and fiber by spray drying. Journal of Food Engineering, v. 123, p. 165-171, 2014.)[032] Research and development of encapsulation of anthocyanidins, astaxanthin, other beta-carotenoids, extracts enriched with anthocyanidins with other fruit pulps and açaí pulp were obtained using different techniques, including spray drying. Research by SHEN & QUEK (2014) developed commercial product microencapsulates, Bioastina® enriched with 5% astaxanthin, and encapsulating agents sunflower oil, wheyprotein, sodium casein and 70 soluble corn fiber. In this composition, the researchers did not use gelatin or aerosil in the composition (SHEN, Q.; QUEK, SY Microencapsulation of astaxanthin with soft milk protein blend and fiber by spray drying. Journal of Food Engineering, v. 123, p. 165-171, 2014.)
[033] Bebida fermentada contendo polpa de Juçara, utilizada como probiótico contendo Lactobacilos reuteri LR92, estudou-se a influência de diferentes carreadores (goma arábica, maltodextrina e gelatina) sobre a sobrevivência dos lactobacilos após secagem por Spray-dryer (GUERGOLETTO, K. B.; BUSANELLO, M.; GARCIA, S. Influence of carrier agentes on the survival of Lactobacillus reuteri LR92 and the physicochemical properties of fermented juçara pulp produced by spray drying. LWT-Food Science and Technology, v. 80, p. 321-327, 2017.) O pó spray-dryer como agente de preservação de Lactobacilos reuteri LR92 foi diferente da nossa invenção, pois não foi incorporado whey protein, aerosil e caseína sódica. Além disso, a bebida incluía goma arábica e maltodextrina agentes não utilizados na invenção apresentada.[033] Fermented drink containing Juçara pulp, used as a probiotic containing Lactobacilli reuteri LR92, the influence of different carriers (gum arabic, maltodextrin and gelatin) on the survival of lactobacilli after drying by Spray-dryer was studied (GUERGOLETTO, KB; BUSANELLO, M.; GARCIA, S. Influence of carrier agents on the survival of Lactobacillus reuteri LR92 and the physicochemical properties of fermented juçara pulp produced by spray drying. LWT-Food Science and Technology, v. 80, p. 321-327, 2017.) The spray-dryer powder as a preserving agent for Lactobacilli reuteri LR92 was different from our invention, as whey protein, aerosil and sodium casein were not incorporated. In addition, the beverage included gum arabic and maltodextrin agents not used in the disclosed invention.
[034] Estudo de estabilidade de antocianidinas e atividade antioxidante de microcápsulas spray-dryer de açaí utilizando diferentes agentes carreadores (maltodextrina 10 DE, maltodextrina 20 DE, goma arábica e amido de tapioca). Maltodextrina 10 DE foi o agente carreador que mostrou maior proteção e com maior atividade antioxidante para a antocianidinas do extrato de spray-dryer de açaí (TONON, R.V.; BRABET, C.; HUBINGER, M.D. Anthocyanin stability and antioxidante activity of spray-dried açai (Euterpe oleracea Mart.) juice produced with diferente carrier agents. Food Research International, v. 43, n. 3, p. 907-914, 2010).[034] Study of stability of anthocyanidins and antioxidant activity of açaí spray-dryer microcapsules using different carrier agents (maltodextrin 10 DE, maltodextrin 20 DE, gum arabic and tapioca starch). Maltodextrin 10 DE was the carrier agent that showed greater protection and greater antioxidant activity for the anthocyanidins of the açaí spray-dryer extract (TONON, RV; BRABET, C.; HUBINGER, MD Anthocyanin stability and antioxidant activity of spray-dried açai (Euterpe oleracea Mart.) juice produced with different carrier agents. Food Research International, v. 43, n. 3, p. 907-914, 2010).
[035] Estudo de microencapsulação de antocianidinas utilizando gel de whey protein e outros agentes emusificantes como fosfatidil colina sem lecitinas e Span 80 mostrou tamanhos de partículas de 20 µm a 70µm, com tamanho médio de 50 µm (BETZ, M.; KULOZIK, U. Microencapsulation of bioactive bilberry anthocyanins by means of whey protein gels. Procedia Food Science, v. 1, p. 2047-2056, 2011).[035] Microencapsulation study of anthocyanidins using whey protein gel and other emusifying agents such as phosphatidyl choline without lecithins and Span 80 showed particle sizes from 20 µm to 70 µm, with a mean size of 50 µm (BETZ, M.; KULOZIK, U) . Microencapsulation of bioactive bilberry anthocyanins by means of whey protein gels. Procedia Food Science, v. 1, p. 2047-2056, 2011).
[036] Estudo da influência da combinação de diferentes materiais de parede (agentes carreadores) sobre a microencapsulação de polpa de Jussara (açaí) por Spray-dryer utilizou mistura ternária de goma arábica, amido modificado, whey protein concentrado ou proteína isolada da soja. A combinação de goma arábica, amido modificado e proteínas fornecem melhores resultados de microencapsulação (SANTANA, A.A. et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v. 212, p. 1-9, 2016).[036] Study of the influence of the combination of different wall materials (carrier agents) on the microencapsulation of Jussara (açaí) pulp by Spray-dryer used a ternary mixture of gum arabic, modified starch, concentrated whey protein or isolated soy protein. The combination of gum arabic, modified starch and proteins provides better microencapsulation results (SANTANA, AA et al. Influence of different combinations of wall materials on the microencapsulation of jussara pulp (Euterpe edulis) by spray drying. Food chemistry, v. 212, p. 1-9, 2016).
[037] A avaliação do efeito das condições de operação sobre o rendimento e qualidade nutricional de pó de açaí combinado com maltodextrina (Maltodextrin MOR-REX 1910) obtido por leito fluidizado. O aumento da temperatura diminui o teor, a umidade, a taxa de fluxo de ar, influenciaram a taxa de degradação de antocianidina e condições ótima de operação foram estabelecidas para obter um pó nutricional energético, baixa umidade, excelente fluidez e alto teor de antocianidinas (COSTA, R.G. et al. Effect of operating conditions on the yield and quality of açai (Euterpe oleracea Mart.) powder produced in spouted bed. LWT-Food Science and Technology, v. 64, n. 2, p. 1196-1203, 2015).[037] The evaluation of the effect of operating conditions on the yield and nutritional quality of açaí powder combined with maltodextrin (Maltodextrin MOR-REX 1910) obtained by fluidized bed. The increase in temperature decreases the content, humidity, air flow rate, influenced the anthocyanidin degradation rate and optimal operating conditions were established to obtain an energetic nutritional powder, low moisture, excellent fluidity and high anthocyanidin content ( COSTA, RG et al., Effect of operating conditions on the yield and quality of açai (Euterpe oleracea Mart.) powder produced in spouted bed, LWT-Food Science and Technology, v. 64, n. 2, p. 2015).
[038] Nenhum dos documentos de patente descritos revela preparações de microcápsulas de polpa de açaí ou microcápsulas contendo extrato padronizado de polpa de açaí ou microcápsulas carregadas com extrato de açaí contendo os ingredientes citados nestas composições aqui apresentadas. As microcápsulas de polpa de açaí apresentam como ingredientes, whey protein, caseína e gelatina e aerosil, bem como microcápsulas de polpa de açaí contendo batata doce e aerosil.[038] None of the patent documents described discloses açaí pulp microcapsule preparations or microcapsules containing standardized açaí pulp extract or microcapsules loaded with açaí extract containing the ingredients cited in these compositions herein. Açaí pulp microcapsules have as ingredients, whey protein, casein and gelatin and aerosil, as well as açaí pulp microcapsules containing sweet potato and aerosil.
[039] Outra característica inovadora destes microencapsulados é o aumento da estabilidade térmica (termoestabilidade) e aumento da fotoestabilidade das substâncias bioativas presentes na polpa de açaí. Os agentes encapsulantes protegem contra ação do calor e da luz impedindo a fácil degradação de substâncias presentes na polpa do açaí, especialmente as antocianidinas. Outra característica inovadora destes microencapsulados é o uso de agentes encapsulantes solúveis em água facilitando a solubilização nos fluidos gastro-intestinais e promovendo a fácil e rápida absorção dos compostos bioativos (flavonoides e antocianidinas). Outra característica inovadora destes microencapsulados é que os encapsulantes protéicos podem trazer outros benefícios quando associados aos compostos bioativos da polpa de açaí como serem utilizados por atletas de academia e de alta performance para prevenir doenças, manter o bem-estar e garantir maior capacidade de treinos devido as propriedades dos encapsulantes protéicos associados aos antioxidantes da polpa de açaí. Desta forma, as modalidades da invenção descritas neste documento apresentam vantagens consideráveis frente ao estado da técnica. O processo de encapsulação não prejudicou a atividade antioxidante dos constituintes presentes na polpa de açaí. As microcápsulas de açaí demonstraram atividade antioxidante utilizando diferentes métodos com DPPH e FRAP.O processo de encapsulação não prejudicou a atividade biológica e manteve a capacidade de reduzir níveis de glicose e níveis de colesterol e triglicerídeos contribuindo assim em processos de dislipidemia e controle da diabetes e hipertensão.[039] Another innovative feature of these microencapsulates is the increase in thermal stability (thermostability) and increased photostability of bioactive substances present in the açaí pulp. Encapsulating agents protect against the action of heat and light, preventing the easy degradation of substances present in the açaí pulp, especially anthocyanidins. Another innovative feature of these microencapsulates is the use of water-soluble encapsulating agents, facilitating solubilization in gastrointestinal fluids and promoting the easy and quick absorption of bioactive compounds (flavonoids and anthocyanidins). Another innovative feature of these microencapsulates is that protein encapsulants can bring other benefits when combined with bioactive compounds from açaí pulp, such as being used by gym and high performance athletes to prevent diseases, maintain well-being and ensure greater training capacity due to the properties of protein encapsulants associated with açaí pulp antioxidants. In this way, the modalities of the invention described in this document present considerable advantages compared to the state of the art. The encapsulation process did not affect the antioxidant activity of the constituents present in the açaí pulp. The açaí microcapsules demonstrated antioxidant activity using different methods with DPPH and FRAP. The encapsulation process did not harm the biological activity and maintained the ability to reduce glucose levels and cholesterol and triglyceride levels, thus contributing to dyslipidemia processes and diabetes control and hypertension.
[040] A invenção proposta no presente documento busca o preenchimento de uma lacuna tecnológica em termos da aplicação da polpa de açaí como elemento ativo de composições nutracêuticas ou farmacêuticas de liberação imediata para ser utilizado como suplemento alimentar, fortificação de alimentos sólidos, fortificação de bebidas ou no tratamento e prevenção de doenças, propondo-se uma forma de liberação imediata dos microencapsulados da polpa de açaí. As microcápsulas de polpa de açaí podem ainda serem utilizados na composição de alimentos funcionais, café expresso, café tradicional, também como suplementos de composição de café verde e seus derivados com o intuito de fortificar a composição de compostos fenólicos e antioxidantes nestas composições pós de complemento vitamínico e minerais para bebidas lácteas e sucos, produtos farináceos (pães, bolos, biscoitos, cookies) em pós, suplementos alimentícios esportivos (whey-protein, caseinatos, albuminas) em pós, para fórmulas de alimentos lácteos gelados (sorvetes, mousses, shakes). Desta forma, propõem-se microcápsulas de polpa de açaí, processos para obtenção de microcápsulas de polpa de açaí e usos destes produtos para preparo de medicamentos com ação antioxidante anti-dislipidêmica, hipoglicemiante, hipocolesterolêmica e hipo-triglicidêmica e melhoria das características sensoriais dos produtos à base de café, chocolate, café verde, produtos farináceoes, suplementos alimentícios esportivos, alimentos lácteos gelados à base de polpa de açaí.[040] The invention proposed in this document seeks to fill a technological gap in terms of the application of açaí pulp as an active element of nutraceutical or pharmaceutical compositions of immediate release to be used as a food supplement, solid food fortification, beverage fortification or in the treatment and prevention of diseases, proposing a form of immediate release of the microencapsulated açaí pulp. Açaí pulp microcapsules can also be used in the composition of functional foods, espresso coffee, traditional coffee, as well as supplements for the composition of green coffee and its derivatives in order to fortify the composition of phenolic compounds and antioxidants in these compositions powders. vitamins and minerals for dairy drinks and juices, farinaceous products (breads, cakes, biscuits, cookies) in powders, sports food supplements (whey-protein, caseinates, albumins) in powders, for frozen dairy food formulas (ice cream, mousses, shakes ). Thus, we propose açaí pulp microcapsules, processes for obtaining açaí pulp microcapsules and uses of these products to prepare medicines with anti-dyslipidemic, hypoglycemic, hypocholesterolemic and hypo-triglycidemic antioxidant action and improve the sensory characteristics of the products based on coffee, chocolate, green coffee, farinaceous products, sports food supplements, iced dairy foods based on açaí pulp.
[041] Cumpre salientar que, a utilização das microcápsulas polpa de açaí é característica determinante na inovação, em termos das tecnologias da própolis, visto que, as antocianidinas, os flavonóides e compostos fenólicos apresenta composição característica, que, terá função primordial na atividade na prevenção e tratamento de doenças.[041] It should be noted that the use of açaí pulp microcapsules is a determining feature in innovation, in terms of propolis technologies, since anthocyanidins, flavonoids and phenolic compounds have a characteristic composition, which will have a primary role in the activity in prevention and treatment of diseases.
[042] Ainda, como diferencial essencial frente ao estado da técnica, as microcápsulas de polpa de açaí propostas na presente invenção, utilizam compostos em uma matriz intermediária de revestimento de bioativos que contêm excipientes farmacêuticos inertes, atóxicos, biocompatíveis, de baixo custo, estáveis com característica reológica para sólidos farmacêuticos ou sólidos nutracêuticos, de liberação imediata e uma matriz externa contendo excipientes nutracêuticos usuais. Desta forma, a composição aqui revelada pode ser usada para solucionar problemas técnicos semi-industriais e industriais nas áreas alimentícia e farmacêutica, bem como algumas aplicações de uso terapêutico.[042] Still, as an essential differential against the state of the art, the açaí pulp microcapsules proposed in the present invention, use compounds in an intermediate matrix of bioactive coating that contain inert, non-toxic, biocompatible, low cost, stable pharmaceutical excipients with rheological characteristics for pharmaceutical solids or nutraceutical solids, immediate release and an external matrix containing usual nutraceutical excipients. Thus, the composition disclosed here can be used to solve semi-industrial and industrial technical problems in the food and pharmaceutical areas, as well as some therapeutic applications.
[043] Além do objetivo já destacado de propor um produto microcápsulas de polpa de açaí de liberação imediata à base substâncias bioativas da polpa do açaí contendo wheyprotein, caseína, gelatina, amido da batata doce e aerosil, a presente invenção propõe uma metodologia para a obtenção desses microcápsulas de polpa de açaí, e os usos para tais produtos com base polpa de açaí.[043] In addition to the already highlighted objective of proposing an immediate release açaí pulp microcapsule product based on bioactive substances from açaí pulp containing wheyprotein, casein, gelatin, sweet potato starch and aerosil, the present invention proposes a methodology for the obtaining these açaí pulp microcapsules, and the uses for such açaí pulp based products.
[044] A presente invenção apresenta microcápsulas de polpa de açaí um tipo de microcápsulas de liberação imediata de polpa de açaí, compostos por polpa de açaí proveniente do extrato bioativo, encapsulante e um promotor de fluidez. Tal sistema dispersante é composto por sistema de encapsulação, que, devido a sua composição permite a liberação imediata do princípio ativo. A invenção trata também do processo de obtenção das microcápsulas de polpa de açaí, por meio da técnica de Spray-Dryer. Adicionalmente, apresenta-se modalidade de invenção em termos de composição contendo os microcápsulas em formulações sólidas, preferencialmente, na forma de pós. Por fim, são apresentados usos para os de liberação modificada de microcápsulas de polpa de açaí e para as composições em questão.[044] The present invention presents açaí pulp microcapsules a type of immediate release açaí pulp microcapsules, composed of açaí pulp from the bioactive extract, encapsulant and a fluidity promoter. Such dispersant system is composed of an encapsulation system, which, due to its composition, allows the immediate release of the active ingredient. The invention also deals with the process of obtaining açaí pulp microcapsules, using the Spray-Dryer technique. Additionally, the embodiment of the invention is presented in terms of the composition containing the microcapsules in solid formulations, preferably in the form of powders. Finally, uses for modified release of açaí pulp microcapsules and for the compositions in question are presented.
[045] A modalidade da invenção, juntamente com vantagens adicionais da mesma podem ser explicadas e compreendidas mediante referência aos desenhos em anexo e a seguinte descrição:[045] The modality of the invention, together with additional advantages thereof can be explained and understood by reference to the attached drawings and the following description:
[046] A Figura 1 anexa apresenta Identificação de antocianidinas por método de UV-vis em diferentes concentrações do extrato da polpa de açaí: (A) Extrato da polpa em diferentes diluições e diferentes concentrações de HCl. (B) Polpa de açaí após processo de clean-up por extração em fase sólida em diferentes diluições.[046] The attached Figure 1 shows Identification of anthocyanidins by UV-vis method at different concentrations of açaí pulp extract: (A) Pulp extract at different dilutions and different concentrations of HCl. (B) Açaí pulp after a clean-up process by solid phase extraction at different dilutions.
[047] A identificação de antocianidinas por espectrofotometria do UV-vis demonstra que o melhor comprimento de onda para identificação e quantificação de antociniadinas utilizando a esptrofotometria UV-vis compreende a faixa de 510nm e 540 nm, visto que os comprimentos de onda de 220nm e 280nm são comprimentos de onda para quantificação de outros flavonoides não antociânicos.[047] The identification of anthocyanidins by UV-vis spectrophotometry demonstrates that the best wavelength for identification and quantification of anthocyanidins using UV-vis spectrophotometry comprises the range of 510nm and 540nm, since the wavelengths of 220nm and 280nm are wavelengths for quantification of other non-anthocyanin flavonoids.
[048] A Figura 2 anexa apresenta cromatogramas (A) Cromatograma de extrato polpa de açaí usando Fluorescência (Ex:250nm – Em:450nm) detectando a presença de antocianidinas (1) e flavonoides (2-Ácido clorogênico, 3- Orientina, 4-Quercitrina, 5-Apigenina); (B) Cromatograma de extrato SPE 30% de MEOH detectando a presença de cianidina cloridrato com tempo de retenção de 22,6 minutos e comprimentos de onda máximos (236nm, 279nm e 518nm).[048] The attached Figure 2 shows chromatograms (A) Chromatogram of açaí pulp extract using Fluorescence (Ex: 250nm - Em:450nm) detecting the presence of anthocyanidins (1) and flavonoids (2-Chlorogenic acid, 3-Orientin, 4 - Quercitrin, 5-Apigenin); (B) Chromatogram of 30% MEOH SPE extract detecting the presence of cyanidin hydrochloride with retention time of 22.6 minutes and maximum wavelengths (236nm, 279nm and 518nm).
[049] A Figura 3 anexa apresenta uma fotomicroscopia de Varredura Eletrônica do microencapsulado 1 com divisão de campo (A) de 50 µm, (B) de 20 µm e (C) de 10 µm. Fotomicroscopia de Varredura Eletrônica do microencapsulado 2 com divisão de campo (D) de 100 µm, (E) de 20 µm e (F) de 10 µm. Fotomicroscopia de Varredura Eletrônica do microencapsulado 3 com divisão de campo (F) de 20 µm (G) de 20 µm e (H) de 5 µm.[049] The attached Figure 3 shows a Scanning Electron photomicroscopy of microencapsulated 1 with field division (A) of 50 µm, (B) of 20 µm and (C) of 10 µm. Scanning Electron Photomicroscopy of microencapsulated 2 with field division (D) of 100 µm, (E) of 20 µm and (F) of 10 µm. Scanning Electron Photomicroscopy of microencapsulated 3 with field division (F) of 20 µm (G) of 20 µm and (H) of 5 µm.
[050] A Figura 4 anexa apresenta a capacidade de sequestro de radical de DPPH em função das concentrações da polpa de açaí e formulações de spray-dryer contendo polpa de açaí.[050] The attached Figure 4 shows the DPPH radical scavenging capacity as a function of açaí pulp concentrations and spray-dryer formulations containing açaí pulp.
[051] A Figura 5 anexa apresenta análise bioquímicas de larvas Tribolium castaneum em diferentes dias incubação suplementadas com formulações microencapsulados de açaí.[051] The attached Figure 5 presents biochemical analysis of Tribolium castaneum larvae in different days of incubation supplemented with microencapsulated formulations of açaí.
[052] A Figura 6 anexa apresenta análise bioquímicas de adultos Tribolium castaneum em diferentes dias incubação suplementadas com formulações microencapsulados de açaí.[052] The attached Figure 6 presents biochemical analysis of Tribolium castaneum adults on different incubation days supplemented with microencapsulated formulations of açaí.
[053] Os microencapsulados de polpa de açaí, também chamados de microcápsulas de polpa de açaí, seus processos e usos descritos na presente invenção podem ser melhor detalhados e compreendidos mediante referência às figuras presentes neste documento e a seguinte descrição:[053] Açaí pulp microencapsulates, also called açaí pulp microcapsules, their processes and uses described in the present invention can be better detailed and understood by referring to the figures in this document and the following description:
[054] As polpas de açaí (Euterpe oleracea) foram obtidas em um fornecedor de açaí no município de Boca da Mata/AL. Após a coleta, 2 Kg das amostras do mesmo lote foram encaminhadas para o laboratório de análise de alimentos da faculdade de Farmácia em caixa de isopor com gelo e colocado em freezer a -20°C até momento da preparação de microencapsulados.[054] The açaí (Euterpe oleracea) pulps were obtained from an açaí supplier in the municipality of Boca da Mata/AL. After collection, 2 Kg of samples from the same batch were sent to the food analysis laboratory of the Faculty of Pharmacy in a Styrofoam box with ice and placed in a freezer at -20°C until the time of preparation of microencapsulates.
[055] Inicialmente foi separado 200mL da polpa do fruto, centrifugado em centrifuga refrigerada Cientec marca CT500E, sob temperatura de 1°C a 5000rpm utilizando tubos falcon de 15mL, em seguida retirado o sobrenadante que resultou em 80mL de extrato. O extrato foi reduzido para um volume de 20 mL usando um rotaevaporador da marca Fisatom, evaporado sob as seguintes condições, temperatura do banho Maria menor que 40°C, velocidade de rotação de 100 rpm e sob pressão 600 mmHg.[055] Initially, 200mL was separated from the fruit pulp, centrifuged in a refrigerated centrifuge Cientec brand CT500E, at a temperature of 1°C at 5000rpm using 15mL falcon tubes, then removed the supernatant that resulted in 80mL of extract. The extract was reduced to a volume of 20 ml using a Fisatom brand rotaevaporator, evaporated under the following conditions, water bath temperature less than 40°C, rotation speed of 100 rpm and pressure 600 mmHg.
[056] O extrato concentrado de açaí (20mL) foi acondicionado em frasco ambar com tampa sob refrigeração a 5°C em geladeira até o momento da análise.[056] The concentrated extract of açaí (20mL) was placed in an amber bottle with a lid under refrigeration at 5°C in a refrigerator until the moment of analysis.
[057] Esse mesmo procedimento foi realizado com um volume de 1Kg da polpa de açaí, e o extrato obtido foi separado em frascos de ampicilina para procedimento de liofilização, o qual foi utilizado no experimento com insetos Tribolium castaneum.[057] This same procedure was performed with a volume of 1Kg of açaí pulp, and the extract obtained was separated in ampicillin bottles for lyophilization procedure, which was used in the experiment with Tribolium castaneum insects.
[058] Foi realizada pelo método de Lee et al. (2005)(LEE, J.; DURST, R.W.; WROLSTAD, R.E. Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: collaborative study. Journal of AOAC international, v. 88, n. 5, p. 1269-1278, 2005) com modificações, no qual um volume de 100µL ou 200 µL do extrato concentrado de açaí foi transferido para balão volumétrico de 10mL. Em seguida o balão foi diluído para 10mL com HCl 0,01% ou 0,037% e submetidos a análise de espectrofotometria do UV-vis na faixa de 200nm a 750nm para obtenção do espectro UV-vis.[058] It was performed by the method of Lee et al. (2005) (LEE, J.; DURST, RW; WROLSTAD, RE Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: collaborative study. Journal of AOAC international, v. 88, n. 5, p. 1269-1278, 2005) with modifications, in which a volume of 100µL or 200 µL of the concentrated açaí extract was transferred to a 10mL volumetric flask. Then, the flask was diluted to 10mL with 0.01% or 0.037% HCl and submitted to UV-vis spectrophotometry analysis in the range of 200nm to 750nm to obtain the UV-vis spectrum.
[059] O extrato concentrado de açaí que estava acondicionado na geladeira foi pesado 130 mg e transferido para um cartucho de extração em fase sólida (EFS) C18 para ensaio de extração clean-up.[059] The concentrated açaí extract that was stored in the refrigerator was weighed 130 mg and transferred to a solid phase extraction cartridge (EFS) C18 for clean-up extraction test.
[060] O cartucho EFS foi acondicionado com 10mL metanol em seguida acondicionado 10mL com ácido clorídrico(HCl) 0,010%. Após a etapa de acondicionamento, 130mg do extrato concentrado de açaí foi aplicado no cartucho C18 e em seguida eluídos com 20mL de diferentes proporções do sistema de fase móvel HCl 0,01%:metanol; iniciando com 90:10 (HCl 0,01%:metanol) seguido das proporções 80:20, 70:30, 60:40, 50:50, 40:60, e 100% de metanol, esta última foi utilizada para limpeza do cartucho, seguindo a metodologia de Cheynier et al. (1994) com modificações.[060] The EFS cartridge was packed with 10mL methanol then packed 10mL with 0.010% hydrochloric acid (HCl). After the conditioning step, 130mg of the concentrated açaí extract was applied to the C18 cartridge and then eluted with 20mL of different proportions of the 0.01% HCl:methanol mobile phase system; starting with 90:10 (0.01% HCl: methanol) followed by the proportions 80:20, 70:30, 60:40, 50:50, 40:60, and 100% methanol, the latter was used for cleaning the cartridge, following the methodology of Cheynier et al. (1994) with modifications.
[061] Os extratos EFS obtidos em diferentes em diferentes proporções foram concentrados em rotaevaporador, sob as mesmas condições descritas anteriormente, para obter volume final de 1mL e em seguida acondicionados na geladeira até o momento da análise.[061] The EFS extracts obtained in different in different proportions were concentrated in a rotaevaporator, under the same conditions described above, to obtain a final volume of 1mL and then stored in the refrigerator until the moment of analysis.
[062] Realizado por cromatografia líquida de alta eficiência (CLAE) segundo o método de Ieri et al. (2011), utilizou- se como fase móvel: solvente A (ácido fórmico 0,1%) e solvente B (acetilnitrila). A coluna cromatográfica foi mantida a temperatura de 33°C coluna C18 marca Phenomenex, modelo Kinetex (100 x 4,6 mm: 5 µm) para análise. Foram utilizados dois detectores UV-vis nos comprimentos de onda de 275nm, 290nm, 320nm, 354nm e 515 nm, e o detector de fluorescência em três comprimentos de excitação e emissão (250nm:450nm; 290nm:450nm; 320nm:450). A fase móvel foi bombeada com um fluxo de 0,4mL em um sistema gradiente iniciando com 3%.[062] Performed by high performance liquid chromatography (HPLC) according to the method of Ieri et al. (2011), the mobile phase used was: solvent A (0.1% formic acid) and solvent B (acetylnitrile). The chromatographic column was maintained at a temperature of 33°C C18 column, brand Phenomenex, model Kinetex (100 x 4.6 mm: 5 µm) for analysis. Two UV-vis detectors were used at wavelengths of 275nm, 290nm, 320nm, 354nm and 515 nm, and a fluorescence detector in three excitation and emission lengths (250nm:450nm; 290nm:450nm; 320nm:450). The mobile phase was pumped at a flow of 0.4mL in a gradient system starting at 3%.
[063] Os padrões de flavonoides utilizados foram vitexina, ácido clorogênico, orientina, quercetina, apigenina, luteolina, miricetrina, rutina, quercitrina, cacetina, crisina, hisperidina, para antocianinas foram cianidina cloridrato adquiridos da extrasynthese® (Lyon Nord, France).[063] The flavonoid standards used were vitexin, chlorogenic acid, orientin, quercetin, apigenin, luteolin, myricetrin, rutin, quercitrin, cacetin, chrysin, hisperidin, for anthocyanins were cyanidin hydrochloride purchased from extrasynthese® (Lyon Nord, France).
[064] Inicialmente, foram pesados todos os componentes das formulações de acordo com a Tabela 1.
Tabela 1. Composição dos microenpsulados spray-dryer de açaí [064] Initially, all components of the formulations were weighed according to Table 1.
Table 1. Composition of açaí spray-dryer microenpsulates
[065] A polpa do açaí, após o processo de filtração em peneira de aço inox, foi submetido a determinação de massa sólida, utilizando balança de infravermelho para determinação de umidade em temperatura de 120°C por período de 20 minutos ou até obter peso constante. A determinação de massa sólida solúvel foi expresso em termo de porcentagens e determinada em triplicata.[065] The açaí pulp, after the filtration process in a stainless steel sieve, was subjected to solid mass determination, using an infrared scale for moisture determination at a temperature of 120°C for a period of 20 minutes or until weight was obtained constant. The determination of soluble solid mass was expressed in terms of percentages and determined in triplicate.
[066] Na formulação 1, inicialmente a polpa foi filtrada em uma peneira inox para remover excessos de goma, reservando a polpa filtrada em um béquer de 200mL. Em outro béquer, o pó de batata doce foi peneirado em uma peneira de granulometria 300µm, e em seguida foi pesado a quantidade de acordo com a tabela 1. O pó de batata doce peneirado foi solubilizado com água destilada sob agitação manual e aquecimento de temperatura de 45°C por 15 minutos. Deixouse em repouso por 15 minutos onde verificou-se precipitação de uma parte do pó da batata doce. Essa suspensão foi filtrada em peneira de aço inox para obter uma solução límpida, a qual foi adicionado a polpa do açaí filtrado, o álcool, e por fim o aerosil.[066] In formulation 1, initially the pulp was filtered through a stainless sieve to remove excess gum, reserving the filtered pulp in a 200mL beaker. In another beaker, the sweet potato powder was sieved in a 300µm particle size sieve, and then the quantity was weighed according to table 1. The sieved sweet potato powder was solubilized with distilled water under manual stirring and temperature heating at 45°C for 15 minutes. It was left to rest for 15 minutes where there was precipitation of a part of the sweet potato powder. This suspension was filtered through a stainless steel sieve to obtain a clear solution, to which the filtered açaí pulp, the alcohol, and finally the aerosil were added.
[067] Quando solubilizado foi submetido ao processamento de Spray-dryer, no qual foi realizado um revestimento com ambientação do equipamento, para não haver perda da amostra.[067] When solubilized, it was subjected to Spray-dryer processing, in which a coating was performed with the equipment's ambiance, so there is no loss of the sample.
[068] Nas formulações 2 e 3 a água foi aquecida a temperatura de 35°C para solubilizar as proteínas (wheyprotein, gelatina e/ou caseina). A solubilização aconteceu sob agitação em equipamento IKA em velocidade de 1800rpm, por um período de 10 a 15 minutos. A polpa foi filtrada em uma peneira inox para eliminação do excesso de gomas e em seguida adicionada na solução de proteínas solúveis. A polpa filtrada de açaí foi adicionada, pouco a pouco, mantendo o sistema sob agitação constante para evitar a precipitação. Em seguida, em outro béquer foi solubilizado a batata doce em 50 mL de água sob agitação manual durante 15 minutos. Deixou-se esse sistema em repouso e o conteúdo do adjuvante 1 foi adicionado à solução de proteínas solúveis contendo polpa de açaí e no final foi adicionado o aerosil mantendo sempre sob agitação constante.[068] In
[069] Quando solubilizado, foi submetido ao processamento de Spray-dryer, com as mesmas condições citadas anteriormente.[069] When solubilized, it was subjected to Spray-dryer processing, with the same conditions mentioned above.
[070] A análise morfológica dos microenpsulados e do extrato da polpa foi realizado com auxílio de em microscópio eletrônico de varredura da TESCAN VEGA 3, com distancia de trabalho de 15,97mm, as amostras foram fixadas em um suporte metálico com auxílio de uma fita dupla face de carbono e recobertas com uma fina camada de ouro. Foi aplicado uma corrente de 45 mA por 200 segundos e aceleração de voltagem igual a 20 kV, no laboratório de Química do Instituto Federal de Alagoas (IFAL).[070] The morphological analysis of the microenpsulates and the pulp extract was carried out with the aid of a scanning electron microscope of
[071] Foram feitas as análises térmicas dos excipientes utilizados nas formulações (polpa de açaí, pó de batata doce e mistura de proteínas) e das três formulações obtidas por Spray-dryer para efeitos de comparação, no laboratório de Química do Instituto Federal de Alagoas (IFAL).[071] Thermal analyzes of the excipients used in the formulations (açaí pulp, sweet potato powder and protein mixture) and of the three formulations obtained by Spray-dryer for comparison purposes were carried out in the Chemistry laboratory of the Federal Institute of Alagoas (IFAL).
[072] A degradação térmica das amostras foi realizada num TGA-50 Shimadzu, com uma atmosfera de nitrogênio e oxigênio a 50 mL/min-1, com uma taxa de aquecimento de 10°C min-1 na faixa de temperatura de 26- 900°C. A massa das amostras analisadas foi de 5,0 ±10%mg.[072] The thermal degradation of the samples was carried out in a TGA-50 Shimadzu, with an atmosphere of nitrogen and oxygen at 50 mL/min-1, with a heating rate of 10°C min-1 in the temperature range of 26- 900°C. The mass of the analyzed samples was 5.0 ±10%mg.
[073] A atividade antioxidante foi determinada utilizando DPPH solubilizado em meio alcoólico (etanol absoluto) segundo Sales (2012). Foram pesados 4 mL do reagente DPPH e solubilizado em um balão volumétrico com capacidade para 100 mL, e a solução obtida foi armazenada sob refrigeração em frasco âmbar.[073] The antioxidant activity was determined using DPPH solubilized in an alcoholic medium (absolute ethanol) according to Sales (2012). 4 mL of DPPH reagent were weighed and solubilized in a volumetric flask with a capacity of 100 mL, and the solution obtained was stored under refrigeration in an amber flask.
[074] Na avaliação da atividade antioxidante foi necessário preparar uma solução estoque de cada uma das formulações. Então foram pesados 130 µg do extrato da polpa de açaí, 260 µg de cada pó da formulação e 300 µL de de polpa com açaí acidificado com HCl 0,037%, solubilizado em balão volumétrico com capacidade para 10 mL, usando 2 mL de água destilada como solvente e álcool até completar o balão, centrifugado e seguindo com a retirada de alíquotas de 750 µL, 500 µL, 250 µL, 100 µL, 50 µL, 25 µL e 10 µL que foram transferidas para balão volumétrico de 5 mL, as análises foram feitas em triplicata.[074] In evaluating the antioxidant activity it was necessary to prepare a stock solution of each of the formulations. Then 130 µg of açaí pulp extract, 260 µg of each powder of the formulation and 300 µL of pulp with açaí acidified with 0.037% HCl were weighed, solubilized in a volumetric flask with a capacity of 10 ml, using 2 ml of distilled water as solvent and alcohol until completing the flask, centrifuged and following with the removal of aliquots of 750 µL, 500 µL, 250 µL, 100 µL, 50 µL, 25 µL and 10 µL, which were transferred to a 5 mL volumetric flask, the analyzes were made in triplicate.
[075] Adicionou-se 2 mL de reagente DPPH incubando por 30 minutos protegido da luz. Decorrido o tempo de reação foi completado o volume do balão com etanol absoluto, realizando em seguida a leitura utilizando espectroscopia UV com comprimento de onda de 518 nm. Os dados foram tratados e a atividade antioxidante foi expressa de acordo com a equação: %AA = 100 –{[(Absamostra – Absbranco) X 100] / Abscontrole}.[075] 2 ml of DPPH reagent were added, incubating for 30 minutes protected from light. After the reaction time, the volume of the flask was completed with absolute ethanol, then reading using UV spectroscopy at a wavelength of 518 nm. The data were treated and the antioxidant activity was expressed according to the equation: %AA = 100 –{[(Abstract – Abswhite) X 100] / Abscontrol}.
[076] A capacidade de redução foi determinada usando o ensaio FRAP de acordo ao método descrito por Benzie e Strain (1996). Foram utilizados para o ensaio diferentes concentrações de extrato de açaí e formulações (10, 25 e 50 µg). O reagente FRAP foi preparado no dia do ensaio, misturando 25mL de tampão acetato (0,3M, pH 3,6), 2,5 mL de solução TPTZ e 2,5 mL de cloreto férico em solução aquosa.[076] The reduction capacity was determined using the FRAP assay according to the method described by Benzie and Strain (1996). Different concentrations of açaí extract and formulations (10, 25 and 50 µg) were used for the test. The FRAP reagent was prepared on the day of the test, mixing 25 ml of acetate buffer (0.3M, pH 3.6), 2.5 ml of TPTZ solution and 2.5 ml of ferric chloride in aqueous solution.
[077] Foi utilizado 90µL das diferentes concentrações das amostras, as quais foram adicionado em um balão volumétrico de 5mL contendo 270mL de água destilada. Em seguida foi adicionado 2,7mL de solução frap e incubado por 30 minutos a 37°C em banho maria. Por fim, a leitura utilizando espectroscopia UV com comprimento de onda de 595 nm. A absorbância obtida foi calculada pela curva de calibação e expressa em µM de sulfato ferroso/g de açaí. O branco das amostras foi o FRAP. Após exatamente 10 min a absorbância (620 nm) foi lida usando um HP Espectrofotômetro 8452a.[077] It was used 90µL of different concentrations of samples, which were added in a 5mL volumetric flask containing 270mL of distilled water. Then, 2.7mL of frap solution was added and incubated for 30 minutes at 37°C in a water bath. Finally, reading using UV spectroscopy with a wavelength of 595 nm. The absorbance obtained was calculated using the calibration curve and expressed in µM of ferrous sulfate/g of açaí. The blank for the samples was FRAP. After exactly 10 min the absorbance (620 nm) was read using an HP Spectrophotometer 8452a.
[078] Foram realizados dois experimentos, um com larvas do Tribolium castaneume o outro com insetos adultos do Tribolium castaneum.
Preparação do experimento com larvas Tribolium castaneum
As larvas de Tribolium castaneum foram obtidas de colônia do Laboratório de Bioquímica e Biologia Molecular de Insetos da Universidade Federal de Alagoas; as larvas foram mantidas a 28 °C com umidade relativa entre 70 e 80%, alimentadas ad libitum. Quatro grupos de 30 larvas, três dias após a eclosão foram submetidos em placas petri à dieta com mistura 300 µg do extrato de açaí e de cada microencapsulados com 300 µg farinha de trigo, adaptada de Sarro et al. (2005) (SARRO, F.B. et al. Feeding substrates to black coconut bunch weevil, Homalinotuscoriaceus (Gyllenhal)(Coleoptera: Curculionidae), rearing in laboratory. Neotropical Entomology, v. 34, n. 3, p. 451-457, 2005) e outro grupo de 30 larvas foi submetido à dieta composta somente de farinha de trigo, em quantidades equivalentes, e todos os grupos realizados em triplicata, mantidos em a 28 °C com umidade relativa entre 70 e 80%. As análises bioquímicas das larvas foram acompanhados durante 4, 5, 8 dias.[078] Two experiments were carried out, one with Tribolium castaneume larvae and the other with adult Tribolium castaneum insects.
Preparation of the experiment with Tribolium castaneum larvae
Tribolium castaneum larvae were obtained from a colony of the Laboratory of Biochemistry and Molecular Biology of Insects at the Federal University of Alagoas; larvae were kept at 28 °C with a relative humidity between 70 and 80%, fed ad libitum. Four groups of 30 larvae, three days after hatching, were submitted to the diet in petri dishes with a mixture of 300 µg of açaí extract and of each microencapsulated with 300 µg wheat flour, adapted from Sarro et al. (2005) (SARRO, FB et al. Feeding substrates to black coconut bunch weevil, Homalinotuscoriaceus (Gyllenhal)(Coleoptera: Curculionidae), rearing in laboratory. Neotropical Entomology, v. 34, n. 3, p. 451-457, 2005 ) and another group of 30 larvae was submitted to a diet composed only of wheat flour, in equivalent amounts, and all groups were carried out in triplicate, kept at 28 °C with a relative humidity between 70 and 80%. Biochemical analyzes of larvae were followed for 4, 5, 8 days.
[079] As larvas de Tribolium castaneum foram obtidas de colônia do Laboratório de Bioquímica e Biologia Molecular de Insetos da Universidade Federal de Alagoas; as larvas foram mantidas a 28 °C com umidade relativa entre 70 e 80%, alimentadas ad libitum. Três grupos de 30 larvas, 12 dias após a eclosão foram submetidos em placas petri à dieta com mistura de 300 µg de cada microencapsulados com 300 µg farinha de trigo, e outro grupo de 30 larvas foi submetido à dieta composta somente de farinha de trigo, em quantidades equivalentes, e todos os grupos realizados em triplicata, mantidos em a 28 °C com umidade relativa entre 70 e 80%. As análises bioquímicas dos adultos foram acompanhados durante 30, 45 e 60 dias.[079] Tribolium castaneum larvae were obtained from a colony of the Laboratory of Biochemistry and Molecular Biology of Insects at the Federal University of Alagoas; larvae were kept at 28 °C with a relative humidity between 70 and 80%, fed ad libitum. Three groups of 30 larvae, 12 days after hatching, were submitted to a diet with a mixture of 300 µg of each microencapsulated with 300 µg of wheat flour in petri dishes, and another group of 30 larvae was submitted to a diet composed only of wheat flour, in equivalent amounts, and all groups performed in triplicate, kept at 28 °C with a relative humidity between 70 and 80%. Biochemical analyzes of adults were followed for 30, 45 and 60 days.
[080] Para avaliação dos níveis de glicose, triglicerídeos, colesterol total e colesterol HDL dos insetos Tribolium casteneum. As larvas e os adultos foram coletadas e adicionadas em solução salina contendo feniltioureia (3-13 mg mL-1) (Sigma Aldrich), maceradas em grau de porcelana, colocadas em eppendorf, centrifugadas (5 min – 13.000 g) e o sobrenadante utilizado. A concentração dos níveis bioquímicos foram determinadas por meio do kit comercial, conforme as instruções do fabricante (Bioclin® Kit enzimático colorimétrico) para cada análise.[080] To assess the levels of glucose, triglycerides, total cholesterol and HDL cholesterol of Tribolium casteneum insects. Larvae and adults were collected and added to saline solution containing phenylthiourea (3-13 mg mL-1) (Sigma Aldrich), macerated in porcelain grade, placed in eppendorf, centrifuged (5 min - 13,000 g) and the supernatant used . The concentration of biochemical levels were determined using the commercial kit, according to the manufacturer's instructions (Bioclin® Colorimetric Enzyme Kit) for each analysis.
[081] Todos os dados são expressos como média ± média do erro padrão. A comparação entre os grupos e diferentes tempos de análise foi realizada pela análise de variância (ANOVA two-way) usando o teste de Bonferroni post tests, com nível de significância de 0,05 e 0,001, no qual as formulações 1, 2 e 3 foram comparadas em relação ao grupo controle. Análise t-Student não pareado com nível de significância <0,05 bicaudal foi utilizado para comparar o grupo controle em relação a cada formulação para cada tempo específico das análises de glicose, colesterol total, triglicerídeos e colesterol HDL.[081] All data are expressed as mean ± mean standard error. The comparison between groups and different times of analysis was performed by analysis of variance (two-way ANOVA) using the Bonferroni post tests, with a significance level of 0.05 and 0.001, in which the
[082] As tabelas 2 e 3 demonstram atividade antioxidante de polpa de açaí e suas microcápsulas de polpa de açaí.[082] Tables 2 and 3 demonstrate antioxidant activity of açaí pulp and its açaí pulp microcapsules.
[083] Tabela 2. Determinação da IC50 e demais parâmetros estatísticos a partir dos dados de atividade antioxidante usando DPPH. [083] Table 2. Determination of IC50 and other statistical parameters from antioxidant activity data using DPPH.
[084] Tabela 3. Atividade antioxidante pelo método FRAP do extrato da polpa de açaí e formulações obtidas por spraydryer em mmol de sulfato ferroso/g de polpa de açaí. [084] Table 3. Antioxidant activity by the FRAP method of açaí pulp extract and formulations obtained by spraydryer in mmol ferrous sulfate/g açaí pulp.
[085] Tabela 4 mostra a perda de massa da polpa de açaí, materiais de revestimento e formulações por TG. [085] Table 4 shows the mass loss of açaí pulp, coating materials and formulations by TG.
Claims (11)
- a) Extrato padronizado da polpa de açaí (Euterpe oleraceae Mart.) proveniente da polpa de açaí em proporção entre 1 a 90%, preferencialmente entre 1 e 80%;
- b) encapsulante em proporção entre 20 e 70%;
- c) e promotor de fluidez em proporção entre 0,01 e 15%;
- a) Standardized extract of açaí pulp (Euterpe oleraceae Mart.) from açaí pulp in a proportion between 1 and 90%, preferably between 1 and 80%;
- b) encapsulant in a proportion between 20 and 70%;
- c) and fluidity promoter in a proportion between 0.01 and 15%;
- i) Obtenção da polpa de açaí in natura ou comercialmente congelada, preferencialmente congelada;
- ii) Preparação do extrato padronizado da polpa de açaí usando tamis padronizado para controlar tamanho de partículas da polpa de açaí, obtido em i);
- iii) Preparação do sistema de emulsificação com uso de encapsulante e promotor de fluidez contendo extrato padronizado de polpa de açaí obtida em ii) e água destilada usando temperatura controlada entre 32 e 37°C, preferencialmente 35°C;
- iv) Redispersão do sistema de emulsificação contendo extrato padronizado de polpa de açaí em sistema de solvente H2O:Etanol, em proporção (1:1, V:V), e preparado em iii);
- v) Secagem do sistema de emulsificação obtido em iv) e formação dos microcápsulas de polpa de açaí por spray-dryer;
- vi) Caracterização dos Microcápsulas de polpa de açaí (Euterpe oleraceae Mart.) usando técnicas de: tamanho de partícula, TG/DTG, FTIR, MEV, HPLC-DAD-UV, fenóis totais, flavonoides totais, atividade antioxidante e ensaios biológicos com Tribolium castaneum e monitorados por ensaios bioquímicos;
- i) Obtaining fresh or commercially frozen açaí pulp, preferably frozen;
- ii) Preparation of standardized açaí pulp extract using standardized sieve to control açaí pulp particle size, obtained in i);
- iii) Preparation of the emulsification system using encapsulant and fluidity promoter containing standardized extract of açaí pulp obtained in ii) and distilled water using controlled temperature between 32 and 37°C, preferably 35°C;
- iv) Redispersion of the emulsification system containing standardized extract of açaí pulp in a H2O:Ethanol solvent system, in proportion (1:1, V:V), and prepared in iii);
- v) Drying of the emulsification system obtained in iv) and formation of açaí pulp microcapsules by spray-dryer;
- vi) Characterization of açaí pulp microcapsules (Euterpe oleraceae Mart.) using techniques such as: particle size, TG/DTG, FTIR, SEM, HPLC-DAD-UV, total phenols, total flavonoids, antioxidant activity and biological assays with Tribolium castaneum and monitored by biochemical assays;
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020005993-9A BR102020005993A2 (en) | 2020-03-25 | 2020-03-25 | AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020005993-9A BR102020005993A2 (en) | 2020-03-25 | 2020-03-25 | AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES |
Publications (1)
Publication Number | Publication Date |
---|---|
BR102020005993A2 true BR102020005993A2 (en) | 2021-10-05 |
Family
ID=90731066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102020005993-9A BR102020005993A2 (en) | 2020-03-25 | 2020-03-25 | AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR102020005993A2 (en) |
-
2020
- 2020-03-25 BR BR102020005993-9A patent/BR102020005993A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Çam et al. | Pomegranate peel phenolics: Microencapsulation, storage stability and potential ingredient for functional food development | |
CN100374044C (en) | Primary composition containing lipophilic bioactive compound | |
US11033566B2 (en) | Method of improving lacrimal secretion for dry eye treatment using maqui berry extract | |
EP2547412B1 (en) | Methods of obtaining natural products from comestible fluids and methods of use | |
CN102159093B (en) | Reducing astringency in compositions containing phenolic compounds | |
JP5147239B2 (en) | Coenzyme Q10-containing emulsion composition | |
US9180077B2 (en) | Green tea extracts of improved bioavailability | |
AU785304B2 (en) | Improvements in or relating to solubilisation of flavonols | |
JP5560289B2 (en) | Natural colorants and methods | |
Mihalcea et al. | Transglutaminase mediated microencapsulation of sea buckthorn supercritical CO2 extract in whey protein isolate and valorization in highly value added food products | |
TW202137886A (en) | Formulation of a turmeric extract comprising curcuminoids, method of production thereof, the use of the formulation and products comprising thereof | |
JP6459206B2 (en) | Superabsorbent ubiquinol formulation | |
US20130184228A1 (en) | Muscadine compositions with anti-oxidant activity | |
US9173916B2 (en) | Method of preparing a muscadine pomace extract | |
BR102020005993A2 (en) | AÇAÍ PULP MICROCAPSULAS (EUTERPE OLERACEA MART.), AÇAÍ MICROCAPSULA PROCESSING PROCESS (EUTERPE OLERACEA MART.) AND USES | |
WO2022180231A1 (en) | Composition comprising an extract of vitis vinifera, vitamin c and probiotics for combating ageing of the skin | |
KR101806220B1 (en) | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction | |
Zahedi et al. | Nanoliposomal Encapsulation of Capparis spinosa Extract and Its Application in Jelly Formulation | |
JP7201164B2 (en) | Agent for activating host defense gene expression by Keap1-Nrf2 system | |
Giaconia et al. | Bioaccessibility and antioxidant activity of anthocyanins from jaboticaba skins: the influence of OSA-modified starch concentration | |
Banerjee et al. | BIOCHEMICAL CHARACTERIZATION AND IN VITRO RELEASE STUDY OF ALGINATE MICROPARTICLES PREPARED WITH INDIAN ROSE (ROSA GRANDIFLORA) FLOWER PIGMENTS | |
BR102019003042A2 (en) | MICROCapsules of Passion Fruit Pulp (PASSIFLORA EDULIS, PROCESS OF OBTAINING MICROCapsules of PASSION FRUIT (PASSIFLORA EDULIS) AND USES | |
EP3903591A1 (en) | Heat stress alleviation agent | |
Bonat Celli | Development of an Oral Delivery System to Modulate the Release of Anthocyanins Extracted from Haskap Berries (Lonicera caerulea L.) | |
WO2024138281A1 (en) | High-fibre, water-dispersible grape marc flour (gmf) nutraceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] |